Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × FED × Etanercept × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Respiratory Distress Syndrome 1 Pneumonia 1 Bronchiolitis Obliterans 1

Interventions

stenoparib 1 sargramostim 1 poly ICLC 1 pembrolizumab 1 copanlisib 1 avelumab 1 Yoga 1 Temozolomide 1 PM 01183 1 Immunoglobulins, Intravenous 1 Hydroxychloroquine 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Ethiodized Oil 1 Etanercept 1 Celecoxib 1 Calcitriol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00029328 2015-03-25

Etanercept for Non-Infectious Lung Injury Following Bone Marrow Transplantation

FDA Office of Orphan Products Development

Phase 1/2 Completed

Bronchiolitis Obliterans, Pneumonia, Respiratory Distress Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡